ATX: L01BC07
Pharmacological group: Antimetabolites - Pyrimidine analogues
Drug form: Lyophilisate for suspension for subcutaneous injection
Dosage and pack size: 100mg in vials in package №1
Indication: Acute myeloid leukemia (AML) in patients who had a first complete remission (CR)